Greenleaf Trust Dr Reddys Laboratories LTD Transaction History

Greenleaf Trust

$11.2 Billion
Q3 2024

A detailed history of Greenleaf Trust transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Greenleaf Trust holds 23,498 shares of RDY stock, worth $369,153. This represents 0.02% of its overall portfolio holdings.

Number of Shares

23,498

Previous 23,498 -0.0%

Holding current value

$369,153

Previous $1.79 Million 4.25%

% of portfolio

0.02%

Previous 0.02%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	BUY	$68.26 - $76.19 $682 - $761	10 Added 0.04%	23,498 $1.79 Million
Q1 2024 Apr 29, 2024	BUY	$67.36 - $77.59 $3,906 - $4,500	58 Added 0.25%	23,488 $1.72 Million
Q4 2023 Jan 31, 2024	SELL	$64.27 - $69.9 $4,434 - $4,823	-69 Reduced 0.29%	23,430 $1.63 Million
Q3 2023 Nov 09, 2023	SELL	$61.9 - $72.77 $17,951 - $21,103	-290 Reduced 1.22%	23,499 $1.57 Million
Q2 2023 Aug 09, 2023	BUY	$53.34 - $63.11 $2,720 - $3,218	51 Added 0.21%	23,789 $1.5 Million
Q1 2023 May 11, 2023	SELL	$51.63 - $56.93 $2,994 - $3,301	-58 Reduced 0.24%	23,738 $1.35 Million
Q4 2022 Jan 25, 2023	BUY	$51.15 - $57.45 $4,756 - $5,342	93 Added 0.39%	23,796 $1.23 Million
Q3 2022 Nov 10, 2022	BUY	$49.9 - $57.32 $2,195 - $2,522	44 Added 0.19%	23,703 $1.24 Million
Q2 2022 Aug 12, 2022	SELL	$49.62 - $58.13 $87,182 - $102,134	-1,757 Reduced 6.91%	23,659 $1.31 Million
Q1 2022 Apr 27, 2022	SELL	$48.27 - $65.25 $122,895 - $166,126	-2,546 Reduced 9.11%	25,416 $1.42 Million
Q4 2021 Feb 11, 2022	BUY	$59.5 - $67.25 $199,920 - $225,960	3,360 Added 13.66%	27,962 $1.83 Million
Q3 2021 Nov 12, 2021	SELL	$60.19 - $75.29 $22,511 - $28,158	-374 Reduced 1.5%	24,602 $1.6 Million
Q2 2021 Aug 10, 2021	SELL	$62.12 - $74.2 $1,615 - $1,929	-26 Reduced 0.1%	24,976 $1.84 Million
Q4 2020 Feb 08, 2021	SELL	$62.61 - $71.29 $9,391 - $10,693	-150 Reduced 0.6%	25,002 $1.78 Million
Q3 2020 Oct 30, 2020	BUY	$51.39 - $72.41 $12,590 - $17,740	245 Added 0.98%	25,152 $1.75 Million
Q2 2020 Aug 12, 2020	BUY	$39.55 - $54.65 $6,802 - $9,399	172 Added 0.7%	24,907 $1.32 Million
Q1 2020 Apr 29, 2020	BUY	$34.75 - $45.85 $288,981 - $381,288	8,316 Added 50.65%	24,735 $998,000
Q4 2019 Feb 11, 2020	BUY	$36.66 - $41.78 $287,707 - $327,889	7,848 Added 91.56%	16,419 $666,000
Q3 2019 Nov 08, 2019	BUY	$34.82 - $39.26 $2,054 - $2,316	59 Added 0.69%	8,571 $325,000
Q2 2019 Jul 24, 2019	BUY	$36.05 - $42.76 $11,860 - $14,068	329 Added 4.02%	8,512 $319,000
Q1 2019 May 08, 2019	SELL	$35.77 - $40.57 $98,939 - $112,216	-2,766 Reduced 25.26%	8,183 $331,000
Q4 2018 Feb 07, 2019	BUY	$31.89 - $38.44 $81,957 - $98,790	2,570 Added 30.67%	10,949 $413,000
Q3 2018 Oct 29, 2018	BUY	$29.25 - $36.73 $48,876 - $61,375	1,671 Added 24.91%	8,379 $290,000
Q2 2018 Aug 07, 2018	SELL	$28.49 - $35.06 $200,882 - $247,208	-7,051 Reduced 51.25%	6,708 $216,000
Q1 2018 Apr 30, 2018	BUY	$31.93 - $39.54 $39,784 - $49,266	1,246 Added 9.96%	13,759 $450,000
Q4 2017 Feb 08, 2018	SELL	$34.15 - $37.62 $39,409 - $43,413	-1,154 Reduced 8.44%	12,513 $470,000
Q3 2017 Nov 13, 2017	BUY	$30.11 - $37.72 $411,513 - $515,519	13,667	13,667 $488,000

Others Institutions Holding RDY

# of Institutions

245

Shares Held

23.1M

Call Options Held

12.7K

Put Options Held

6.1K

View Full List

About DR REDDYS LABORATORIES LTD

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.61B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

More about RDY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenleaf Trust, based on Form 13F filings with the SEC.

News

Stay updated on Greenleaf Trust with notifications on news.

Account